Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and Type II diabetes

被引:169
|
作者
Yuan, X
Yamada, K
Ishiyama-Shigemoto, S
Koyama, W
Nonaka, K
机构
[1] Kurume Univ, Div Endocrinol & Metab, Dept Med, Sch Med, Kurume, Fukuoka 8300011, Japan
[2] Kumamoto Red Cross Hlth Care Ctr, Kumamoto, Japan
关键词
serotonin; 5-HT2C receptor; promoter; polymorphism; obesity;
D O I
10.1007/s001250050056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. Polymorphisms in the upstream region of the 5-MT2C receptor gene could play a part in the development of obesity. Methods. We screened the upstream region from 27 men by the single strand conformational polymorphism analysis and PCR-direct sequencing and then genotyped 466 non-obese (body mass index < 28 kg/ m(2)) and 123 obese (greater than or equal to 28 kg/m(2)) men including 138 patients with Type II (non-insulin-dependent) diabetes mellitus. Results. Three loci of single nucleotide substitution (G-->A at -995, C-->T at -759, G-->C at -697) and a (GT)n dinucleotide repeat polymorphism at -1,027 were identified. The frequency of -995/-759 and -697 variants was higher in non-obese subjects and that of -995/-759 variants in non-diabetic subjects. In the dinucleotide repeat locus, five alleles were detected including Z containing 17 repeats. The Z-6 allele was more common in non-obese subjects and the Z + 2 allele in obese subjects. Haplotype 3 (Z-6, -995A, -759T, -697C) was associated with leanness (p = 0.02) and the absence of diabetes (p = 0.033) and haplotype 9 (Z + 2, -995G, -759C, -697G) with obesity (p = 0.007). Haplotype 2 (Z-6, -995G, -759C, -697C) tended to be more common in nonobese subjects. A luciferase reporter assay showed that haplotype 2 and haplotype 3 had 1.44- or 2.58-fold higher promoter activities than the most common haplotype 6 (Z, -995G, -759C, -697G). Conclusion/interpretation. The haplotypes containing the nucleotide substitutions could be associated with higher transcription levels of the gene and thereby with resistance to obesity and Type II diabetes. Promoter polymorphisms of the 5-MT2C receptor gene may play an important part in genetic predisposition to the disorders.
引用
收藏
页码:373 / 376
页数:4
相关论文
共 50 条
  • [1] Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and Type II diabetes
    X. Yuan
    K. Yamada
    S. Ishiyama-Shigemoto
    W. Koyama
    K. Nonaka
    Diabetologia, 2000, 43 : 373 - 376
  • [2] Association of a polymorphism in the promoter region of the serotonin 5-HT2C receptor gene with tardive dyskinesia in patients with schizophrenia
    Zhang, ZJ
    Zhang, XB
    Sha, WW
    Zhang, XB
    Reynolds, G
    MOLECULAR PSYCHIATRY, 2002, 7 (07) : 670 - 671
  • [3] 5-HT2C receptor ligands in the treatment of obesity and type 2 diabetes
    Heisler, L. K.
    Lam, D. D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S182 - S182
  • [4] Serotonin 5-HT2C receptor agonists:: For the treatment of obesity
    Miller, KJ
    MOLECULAR INTERVENTIONS, 2005, 5 (05) : 282 - 291
  • [5] Polymorphism of the promoter region of the serotonin 5-HT2C receptor gene and clozapine-induced weight gain
    Reynolds, GP
    Zhang, ZJ
    Zhang, XB
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (04): : 677 - 679
  • [6] Identification of a new polymorphism in the 3′-untranslated region of the human serotonin receptor 2C (5-HT2C) gene
    Song, HR
    Gu, A
    Schanen, NC
    MOLECULAR GENETICS AND METABOLISM, 1999, 66 (03) : 224 - 227
  • [7] A Positive Allosteric Modulator of the Serotonin 5-HT2c Receptor for Obesity
    Garcia-Carceles, Javier
    Decara, Juan M.
    Vazquez-Villa, Henar
    Rodriguez, Ramon
    Codesido, Eva
    Cruces, Jacobo
    Brea, Jose
    Loza, Maria I.
    Alen, Francisco
    Botta, Joaquin
    McCormick, Peter J.
    Ballesteros, Juan A.
    Benhamu, Bellinda
    Rodriguez de Fonseca, Fernando
    Lopez-Rodriguez, Maria L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (23) : 9575 - 9584
  • [8] Epilepsy and obesity in serotonin 5-HT2C receptor mutant mice
    Heisler, LK
    Chu, HM
    Tecott, LH
    ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 : 74 - 78
  • [9] Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene
    Nonogaki, K
    Strack, AM
    Dallman, MF
    Tecott, LH
    NATURE MEDICINE, 1998, 4 (10) : 1152 - 1156
  • [10] Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene
    Katsunori Nonogaki
    Alison M. Strack
    Mary F. Dallman
    Laurence H. Tecott
    Nature Medicine, 1998, 4 : 1152 - 1156